Salusin-Beta vs Urotensin-II — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Salusin-beta is a 20-amino acid vasoactive peptide derived from the TOR2A (torsin family 2 member A) gene, which also encodes the related peptide salusin-alpha (28 aa). Discovered in 2003 by Shichiri et al....
Calculate Salusin-Beta dose →Human Urotensin-II (U-II) is an 11-amino acid cyclic peptide and the most potent mammalian vasoconstrictor identified to date - approximately 10 to 20 times more potent than endothelin-1 in isolated vascular preparations. Originally characterized in fish urophysis (caudal neurose...
Calculate Urotensin-II dose →| Parameter | Salusin-Beta | Urotensin-II |
|---|---|---|
| Category | Vasoactive Peptide | Vasoactive Peptide |
| Research | Research | Active Research |
| Half-Life | Unknown | ~30 minutes (plasma) |
| Typical Dose | 1-100 nmol/kg (animal) | 0.01-1 nmol/kg/min IV (animal); picomolar concentrations produce vasoconstriction |
| Frequency | Variable | Acute infusion |
| Route | Intravenous, Subcutaneous | IV infusion (research/clinical studies) |
| FDA Status | Not approved | Research compound; UT receptor antagonists in clinical trials |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.